Physician profile
Kellvan J Cheng
NPI 1538187067
$3,762.69
in general payments reported to CMS, 2019-2025
16 companies · $566 in 2025
The $566 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $178 · 2020: $243 · 2021: $19.64 · 2022: $24.82 · 2023: $1,769 · 2024: $962 · 2025: $566.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,597 · Travel and Lodging: $1,455 · Long Term Medical Supply Or Device Loan: $245.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,596.74 |
| Travel and Lodging | $1,454.68 |
| Long Term Medical Supply Or Device Loan | $245.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,864.30 | 2020-2025 | Salvation, Prostep, Augment Injectable |
| Integra Lifesciences Corporation | $411.03 | 2024 | Integra, Acell, Primatrix |
| Nvision Biomedical Technologies, INC. | $388.93 | 2024 | Radian |
| Abbott Laboratories | $235.00 | 2023 | Eterna, Penta |
| Medtronic Vascular, INC. | $177.68 | 2019-2020 | |
| Medline Industries Lp | $161.12 | 2025 | |
| Polynovo North America LLC | $155.26 | 2025 | Novosorb Btm |
| Biotronik Nro, INC. | $128.95 | 2024 | Prospera |
| Nevro Corp. | $61.82 | 2023 | Senza |
| Acumed LLC | $44.18 | 2019 | |
| Organogenesis INC. | $35.89 | 2021-2023 | Puraply |
| Davol INC. | $24.82 | 2022 | |
| Orthofix Medical, INC. | $24.36 | 2025 | Physio-Stim |
| Pacira Pharmaceuticals Incorporated | $17.59 | 2019 | |
| Maxx Health INC | $17.44 | 2023 | Summa Ortho Optossol, Summa Ortho Foot |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $14.32 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kellvan Cheng listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.